Diacerein

Diacerein

SCHEMBL29944894

CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 9/20 1.00
ALDH1A1 P00352 5/20 1.00
KDM4E B2RXH2 4/20 1.00
HPGD P15428 3/20 1.00
MEN1 O00255 2/20 1.00
LMNA P02545 2/20 1.00
HSP90AA1 P07900 2/20 1.00
HSP90AB1 P08238 2/20 1.00
MAPT P10636 2/20 1.00
CASP7 P55210 2/20 1.00
KMT2A Q03164 2/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
FTO Q9C0B1 2/20 1.00
MAPK1 P28482 2/20 1.00
ABCC4 O15439 1/20 1.00
USP2 O75604 1/20 1.00
TP53 P04637 1/20 1.00
CHRM2 P08172 1/20 1.00
HTR1A P08908 1/20 1.00
ADRA2A P08913 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diacerein SCHEMBL5051685 1.00 TTR (1.00) TTRALDH1A1KDM4EHPGDMEN1
Diacerein SCHEMBL25784 1.00 TTR (1.00) TTRALDH1A1KDM4EHPGDMEN1
Diacerein SCHEMBL29423907 1.00 TTR (1.00) TTRALDH1A1KDM4EHPGDMEN1
Diacerein SCHEMBL7438555 0.99 TTR (0.97) TTRALDH1A1KDM4EHPGDMEN1
Diacerein SCHEMBL5078956 0.99 TTR (0.97) TTRALDH1A1KDM4EHPGDMEN1
Diacerein SCHEMBL787907 0.99 TTR (0.97) TTRALDH1A1KDM4EHPGDMEN1
Diacerein SCHEMBL2326532 0.93 TTR (0.86) TTRALDH1A1KDM4EHPGDMEN1
SCHEMBL23655432 0.92 TTR (0.84) TTRALDH1A1KDM4EHPGDMEN1
Diacerein SCHEMBL5712120 0.92 MEN1 (0.84) TTRALDH1A1KDM4EHPGDMEN1
SCHEMBL16549421 0.90 TTR (0.82) TTRALDH1A1KDM4EHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119504428-A Preparation method of diacerein impurity 珠海安哲生物科技有限公司 2025-02-25 CN disclosed
CN-112279767-B Preparation method of diacerein 陕西嘉禾生物科技股份有限公司 2023-02-03 CN disclosed
US-20230011269-A1 PHARMACEUTICAL COMPOSITION COMPRISING A POTENT INHIBITOR OF URAT1 ASTRAZENECA AB (SE) 2023-01-12 US disclosed
CN-110177547-B Compositions for the treatment of inflammatory bowel disease and enterocolitis 台睿生物科技股份有限公司 2022-09-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230011269-A1 PHARMACEUTICAL COMPOSITION COMPRISING A POTENT INHIBITOR OF URAT1 UGP2, MPST, SLC10A1 TTR 705/4885ALDH1A1 822/4885KDM4E 1462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.